<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Biochem Nutr</journal-id><journal-id journal-id-type="publisher-id">JCBN</journal-id><journal-title-group><journal-title>Journal of Clinical Biochemistry and Nutrition</journal-title></journal-title-group><issn pub-type="ppub">0912-0009</issn><issn pub-type="epub">1880-5086</issn><publisher><publisher-name>the Society for Free Radical Research Japan</publisher-name><publisher-loc>Kyoto, Japan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22448099</article-id><article-id pub-id-type="pmc">3303480</article-id><article-id pub-id-type="publisher-id">jcbn11-55</article-id><article-id pub-id-type="doi">10.3164/jcbn.11-55</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Amino acid and vitamin supplementation improved health conditions in elderly participants</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ohtani</surname><given-names>Masaru</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kawada</surname><given-names>Shigeo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Seki</surname><given-names>Taizo</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Okamoto</surname><given-names>Yasuyuki</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Human and Engineered Environmental Studies, Graduate School of Frontier Sciences, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa-shi, Chiba 277-8563, Japan</aff><aff id="aff2"><label>2</label>Laboratory of Tissue Plasticity Science, Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan</aff><aff id="aff3"><label>3</label>Future Institute for Sport Sciences, Waseda University, 1-6-1 Nishiwaseda, Shinjuku-ku, Tokyo 169-8050, Japan</aff><aff id="aff4"><label>4</label>Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 464-8601, Japan</aff><aff id="aff5"><label>5</label>Sansei Hospital, 4-2-5 Kotonoo-cho, Chyuo-ku, Kobe-shi, Hyogo 651-0094, Japan</aff><author-notes><corresp id="cor1">*To whom correspondence should be addressed. E-mail: <email>kawada@idaten.c.u-tokyo.ac.jp</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>5</day><month>11</month><year>2011</year></pub-date><volume>50</volume><issue>2</issue><fpage>162</fpage><lpage>168</lpage><history><date date-type="received"><day>28</day><month>4</month><year>2011</year></date><date date-type="accepted"><day>10</day><month>6</month><year>2011</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2012 JCBN</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The purpose of this study was to investigate the effects of supplementation with amino acids and vitamins on health conditions in unhealthy older people. One bedridden inpatient group (<italic>n</italic>&#x000a0;=&#x000a0;10; mean age, 79.8&#x000a0;&#x000b1;&#x000a0;8.5 y) and one outpatient group (<italic>n</italic>&#x000a0;=&#x000a0;9; mean age, 72.9&#x000a0;&#x000b1;&#x000a0;12.2 y) participated in this study. A mixture supplementation with amino acids containing arginine (500&#x000a0;mg/day), glutamine (600&#x000a0;mg/day), and leucine (1200&#x000a0;mg/day), and 11 kinds of vitamins was daily administrated for 8 weeks. In both groups, general blood biomarkers such as white blood cell count, natural killer cell activity, and C-reactive protein levels were measured. All measurements were taken before (baseline), at 4 weeks (mid-point), and after each trial (post-point). At mid-point, natural killer cell activity in the outpatient group increased significantly compared to baseline. At post-point, natural killer cell activity in the outpatient and inpatient groups increased significantly compared to baseline. The other blood biomarkers did not show any significant change throughout the trial. This pilot study suggested that a mixture of arginine, glutamine, leucine, and vitamins is useful to support innate immunity in unhealthy older people, even if their diseases, symptoms, and prescribed medicines are different.</p></abstract><kwd-group><kwd>amino acids</kwd><kwd>immune function</kwd><kwd>bedridden older inpatients</kwd><kwd>older outpatients</kwd><kwd>natural killer cell activity</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>As people age, the incidence of age-related health diseases such as cerebral infarction, cardiovascular disease, and diabetes increases. Besides these primary diseases, aging is also associated with attenuation of the immune system.<sup>(<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>)</sup> While medical care for primary diseases is important, support for the immune system is also required in the elderly patients. Because many of them already take a variety of medicines for their primary diseases, most would prefer not to take more.</p><p>Nutritional supplementation with amino acids and vitamins has been shown to affect immune variables. Glutamine and arginine are thought to be good candidates for immune system support.<sup>(<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>)</sup> Glutamine is the most abundant free amino acid in blood and constitutes more than 50% of the amino acid pool in human skeletal muscle. Macrophages and lymphocytes contributing to the immune system require glutamine as a fuel.<sup>(<xref ref-type="bibr" rid="B5">5</xref>)</sup> It has been observed that glutamine causes neutrophils to increase their phagocytic activity in a dose-dependent manner.<sup>(<xref ref-type="bibr" rid="B6">6</xref>)</sup> Glutamine is also utilized as a major fuel source by intestinal mucosal cells and influences the gut-associated immune system.<sup>(<xref ref-type="bibr" rid="B7">7</xref>&#x02013;<xref ref-type="bibr" rid="B9">9</xref>)</sup> In an <italic>in vitro</italic> study, glutamine decreased the tumor necrosis factor &#x003b1;-mediated bacterial translocation in enterocytes.<sup>(<xref ref-type="bibr" rid="B10">10</xref>)</sup> Another <italic>in vivo</italic> study demonstrated that glutamine-supplemented rat group with an obstructed terminal ileum had fewer positive cultures in blood after injection of <italic>E coli</italic> into the ileal lumen.<sup>(<xref ref-type="bibr" rid="B11">11</xref>)</sup> Although glutamine is not an essential amino acid, it is considered to be a conditionally essential amino acid because its plasma levels decrease sharply when people are critically ill.<sup>(<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>)</sup> Arginine is also a nonessential amino acid, but has been reported to become conditionally essential in the critically ill.<sup>(<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>)</sup> It has been observed that arginine prevents thymic involution after surgery and increases the number of lymphocytes. Therefore, it acts as a potent modulator of immune function.<sup>(<xref ref-type="bibr" rid="B16">16</xref>&#x02013;<xref ref-type="bibr" rid="B18">18</xref>)</sup> Several studies have demonstrated that arginine intake improves T-cell activity, neutrophil chemotaxis, and natural killer (NK) cytotoxicity.<sup>(<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B19">19</xref>&#x02013;<xref ref-type="bibr" rid="B21">21</xref>)</sup> Moreover, multivitamin, including vitamin C and E, is known to improve immunity.<sup>(<xref ref-type="bibr" rid="B22">22</xref>)</sup> It has been observed that various types of diseases such as cancer and hypertension produce reactive oxygen species that impair immune function.<sup>(<xref ref-type="bibr" rid="B23">23</xref>&#x02013;<xref ref-type="bibr" rid="B25">25</xref>)</sup> Therefore, antioxidant effects of vitamins are thought to be beneficial for maintenance of the immune function.</p><p>In addition to attenuation of immune function, involuntary loss of muscle mass with aging (sarcopenia) is also a serious problem for maintaining a quality of life. Although resistance exercise programs are recommended for the elderly to prevent sarcopenia, it is difficult for them to engage in these because many of them suffer from multiple diseases. Therefore, nutritional approaches to prevent sarcopenia have been evaluated. It has been observed that leucine, an essential amino acid, activates intracellular kinases linked to the translation of proteins such as those associated with the mammalian target of rapamycin signaling pathway, which includes the 70-kDa ribosomal protein S6 kinase and eukaryotic initiation factor 4E-binding protein 1, leading to stimulation of muscle protein synthesis.<sup>(<xref ref-type="bibr" rid="B26">26</xref>&#x02013;<xref ref-type="bibr" rid="B29">29</xref>)</sup> It has been observed that supplementation with a high proportion of leucine in an oral mixture of essential amino acids resulted in an additional 0.008% per hour increase in the postprandial muscle protein synthetic rate for 2.5&#x000a0;h in healthy older men.<sup>(<xref ref-type="bibr" rid="B30">30</xref>)</sup></p><p>Based on these studies, we hypothesized that supplementation with a mixture of glutamine, arginine, leucine, and vitamins may have beneficial health effects on the elderly in poor health.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Bedridden inpatients</title><p>Thirteen bedridden inpatients (7 males, 6 females; mean age, 81.8&#x000a0;&#x000b1;&#x000a0;8 years) participated in this study. The hospitalized duration of the bedridden inpatients was 16.4&#x000a0;&#x000b1;&#x000a0;7.6 months. All participants were Japanese; their health status and the prescription drugs they were taking are summarized in Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>. Eleven of 13 bedridden inpatients underwent percutaneous endoscopic gastrostomy (PEG). Three bedridden inpatients dropped out for the following reasons: 1 (female) had gastritis, 1 (male) had pneumonia, and 1 (male) was moved to another hospital. Doctors confirmed that the causes of discontinuance were not attributed to this trial.</p></sec><sec><title>Outpatients</title><p>Eleven outpatients (7 males, 4 females; mean age, 74&#x000a0;&#x000b1;&#x000a0;12 years; body mass index, 21.0&#x000a0;&#x000b1;&#x000a0;3.7) from the Sansei Hospital (Hyogo Prefecture, Japan) participated in this study. The duration of ambulatory visits to the hospital for the outpatients was 117.6&#x000a0;&#x000b1;&#x000a0;64.0 months. All participants were Japanese; their health status and the prescription drugs they were taking are summarized in Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>. Two male outpatients dropped out, 1 because of hospitalization (worsening of prostate cancer) and 1 because of a bone fracture. Doctors confirmed that the causes of discontinuance were not attributed to this trial.</p></sec><sec><title>Experimental procedures</title><p>Administering a placebo to patients as a control group was not agreeable to them and their families. Therefore, in this study we could not set the placebo group. All experimental procedures were performed in accordance with the Declaration of Helsinki. All participants and their families were informed about the experimental procedures and purpose of the study, and they gave written informed consent prior to participation. The ethics committee of the Sansei Hospital approved this study. The duration of this study was 8 weeks.</p></sec><sec><title>Diet and supplementation programs for the bedridden inpatients</title><p>The bedridden inpatient participants were administered a liquid diet (Isocal 2K, Nestle Nutrition Co., Tokyo, Japan) twice (morning and evening) daily. The composition of the diet is presented in Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>. The amount of the liquid diet was determined by medical doctors according to the participants&#x02019; health conditions (mean total calorie, 1147&#x000a0;&#x000b1;&#x000a0;334&#x000a0;kcal/day; mean protein intake, 39.0&#x000a0;&#x000b1;&#x000a0;11.3&#x000a0;g/day). A powder containing amino acids and vitamins was mixed in the diet. To avoid malabsorption, the powder was mixed with each of the two daily doses of the liquid diet. The composition of the supplementation is presented in Table&#x000a0;<xref ref-type="table" rid="T3">3</xref>. This composition was based on our previous studies in which it improved health conditions in young male athletes.<sup>(<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>)</sup></p></sec><sec><title>Diet and supplementation programs for the outpatients</title><p>The same amino acid and vitamin supplementation as the inpatients was administered to the outpatients with water twice daily, immediately after dinner and before sleeping. Because they already took a variety of medicines with water for their primary diseases from morning to evening, to avoid satiety, most of them preferred to take the supplementation at evening and before sleep. When the supplementation was administered to the outpatients, they recorded it on a check sheet. The researchers subsequently confirmed the compliance of their supplementation programs. The daily diet of the outpatients was almost the same throughout the trial period except for the additional amino acid and vitamin supplementation. Their habitual nutrient intake was analyzed using food-frequency questionnaires.<sup>(<xref ref-type="bibr" rid="B33">33</xref>)</sup></p></sec><sec><title>Anthropometric evaluation</title><p>Initially, the outpatient participants were subjected to anthropometric evaluation. The anthropometric evaluation included height, body weight, and body composition comprising fat and lean body mass. Body composition was evaluated by bioimpedance (X-Scan plus, Owa Medical Co., Fukuoka, Japan). This system applies to a constant current of 100&#x000a0;&#x000b5;A at 1, 5, 50, 250, and 550&#x000a0;kHz, and 280&#x000a0;&#x000b5;A at 1000&#x000a0;kHz thorough the body. Subjects restrained from vigorous exercise and alcohol intake during 24&#x000a0;h, preceding the measurements. The room temperature was kept at 23&#x000b0;C. Bioimpedance measurements of whole body were theoretically based on a previous study.<sup>(<xref ref-type="bibr" rid="B34">34</xref>)</sup> The participants did not agree to using computed tomography and dual energy X-ray absorptiometry to evaluate body composition owing to concerns of radiation exposure. Anthropometric evaluations were not performed for bedridden inpatients because they faced difficulty in standing.</p></sec><sec><title>Blood sampling and measurement of body temperature</title><p>Fasting venous blood samples were collected from each subject at least 24&#x000a0;h before the trial (baseline), on the last day of the 4-week (mid-point) period and on the last day of the 8-week (post-point) period. The body temperature of bedridden inpatients was measured daily. The number of days on which had a fever above 37&#x000b0;C was counted and the frequency (febrile frequency, the number of days for which body temperature was more than 37&#x000b0;C/the number of days per month &#x000d7;100) was compared with that of control inpatients (<italic>n</italic>&#x000a0;=&#x000a0;11) who did not participate in this study but were hospitalized in the same room as the participating inpatients. The control inpatients underwent PEG and were administered the same liquid diet as the inpatient participants (mean total calorie, 1140&#x000a0;&#x000b1;&#x000a0;134&#x000a0;kcal/day; mean protein intake, 38.8&#x000a0;&#x000b1;&#x000a0;5.0&#x000a0;g/day).</p></sec><sec><title>Blood analyses</title><p>Complete blood count and hematocrit were analyzed using an automated hematology analyzer (Coulter Electronics, Hialeah, FL). Concentrations of total plasma proteins, serum albumin, blood urea nitrogen, serum creatinine, and serum amylase activity were determined by routine methods. Serum aspartate aminotransferase, alanine aminotransferase, leucine aminopeptidase, cholinesterase, gamma-glutamyltranspeptidase, and total bilirubin levels were used as liver function markers and measured by routine methods. C-reactive protein (CRP) level was used as an inflammation marker and measured using a latex agglutination immunoassay (EIKEN Chemical, Co. Ltd., Tokyo, Japan). To measure the <italic>in vitro</italic> tumoricidal activity of NK cells, cytotoxicity was measured by determining the amount of <sup>51</sup>Cr released from target cells at an effector&#x000a0;:&#x000a0;target (E/T) ratio of 20:1.<sup>(<xref ref-type="bibr" rid="B35">35</xref>)</sup> Blood samples were centrifuged at 1500&#x000a0;&#x000d7;&#x000a0;<italic>g</italic> (20&#x000b0;C) for 20&#x000a0;min and then 200&#x000a0;&#x000b5;L of prepared lymphocyte cells (1&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells/ml) and 10&#x000a0;&#x000b5;L of prepared K562 human chronic myelogenous leukemia cells (1&#x000a0;&#x000d7;&#x000a0;10<sup>6</sup> cells/ml) labeled with <sup>51</sup>Cr were added to a plate. The plate was then incubated for 3.5&#x000a0;h at 37&#x000b0;C in an atmosphere of 5% CO<sub>2</sub>. Following incubation, the activity of NK cells was counted using a scintillation counter (Perkin Elmer Japan Co. Ltd., Kanagawa, Japan).</p></sec><sec><title>Statistical analysis</title><p>The data of dropped out participants were excluded from the data analyses. All data were expressed as mean&#x000a0;&#x000b1;&#x000a0;SD. The differences between the variables were examined by one-way analysis of variance (ANOVA), followed by Fisher&#x02019;s protected least significant difference post-hoc test. Body temperature data were examined using 2 (condition) &#x000d7;2 (time of measurement) ANOVA for interaction and main effects. When a statistical significance was obtained, Student&#x02019;s <italic>t</italic> test was used to compare the 2 groups and for comparisons within the same group. Statistical significance was accepted at the <italic>p</italic>&#x000a0;=&#x000a0;0.05 level.</p></sec></sec><sec><title>Results</title><p>The outpatients mean habitual nutrient intake was 34.1&#x000a0;&#x000b1;&#x000a0;3.8 kcal/kg/day including 1.27&#x000a0;&#x000b1;&#x000a0;0.32&#x000a0;g protein/kg/day. Body weight and body composition in the outpatients did not change throughout the trial (Fig.&#x000a0;<xref ref-type="fig" rid="F1">1</xref>a). At mid-point, NK cell activity in the bedridden inpatients tended to increase compared to baseline (<italic>p</italic>&#x000a0;=&#x000a0;0.08), and at post-point, it increased significantly compared to baseline (<italic>p</italic>&#x000a0;=&#x000a0;0.03) (Fig.&#x000a0;<xref ref-type="fig" rid="F1">1</xref>b). At mid-point (<italic>p</italic>&#x000a0;=&#x000a0;0.01) and post-point (<italic>p</italic>&#x000a0;=&#x000a0;0.001), NK cell activity in the outpatients increased significantly compared to baseline (Fig.&#x000a0;<xref ref-type="fig" rid="F1">1</xref>b). The other biomarkers did not change throughout the trial (Table&#x000a0;<xref ref-type="table" rid="T4">4</xref>). Febrile frequency in the bedridden inpatients did not change throughout the trial, whereas at the second month in the control inpatients, it increased significantly compared to the first month (<italic>p</italic>&#x000a0;=&#x000a0;0.03) (Fig.&#x000a0;<xref ref-type="fig" rid="F2">2</xref>). Febrile frequency did not show a condition &#x000d7; time interaction.</p></sec><sec><title>Discussion</title><p>In this study, we investigated whether supplementation of a combination of glutamine, arginine, leucine, and 11 kinds of vitamins had beneficial effects on the health of older people in poor health. The aging process in humans results in sarcopenia, which involves loss of skeletal muscle mass and function leading to metabolic diseases such as obesity and type 2 diabetes.<sup>(<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B37">37</xref>)</sup> To improve body composition, older outpatients in this study were administered a powder containing leucine because it activates muscle protein synthesis. It has been shown that ingestion of 6.7&#x000a0;g of essential amino acids containing 2.75&#x000a0;g of leucine increases muscle protein synthesis (increase of 0.008% per hour) in younger and older people.<sup>(<xref ref-type="bibr" rid="B30">30</xref>)</sup> The outpatients in this study were each administered 600&#x000a0;mg of leucine immediately after dinner and before sleeping. Because the outpatients had dinner every evening, it was thought that total leucine intake over a short duration in the evenings was at least above 1.2&#x000a0;g. Extrapolation of these data toward the effect of leucine supplementation with dinner for 8 weeks would theoretically result in almost a 0.3&#x000a0;kg gain in muscle mass. However, an 8-week period of leucine supplementation did not increase lean body mass in the outpatients (Fig.&#x000a0;<xref ref-type="fig" rid="F1">1</xref>a). It has been shown that ingestion of 6.7&#x000a0;g of essential amino acids containing 2.75&#x000a0;g of leucine increased muscle protein synthesis, whereas 7.5&#x000a0;g/day of leucine supplementation for 3 months did not induce any changes in the muscle mass and strength of healthy elderly people.<sup>(<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B38">38</xref>)</sup> However, it is thought that muscle protein synthesis is influenced by daily total protein or leucine intake. A daily protein intake above 0.85&#x000a0;g protein/kg body weight is adequate for older people.<sup>(<xref ref-type="bibr" rid="B39">39</xref>)</sup> It has been shown that muscle mass does not increase in subjects whose habitual protein intake is approximately 78&#x000a0;g/day, even if administered 7.5&#x000a0;g/day of leucine for 3 months.<sup>(<xref ref-type="bibr" rid="B38">38</xref>)</sup> The outpatients daily protein intake in this study was above 0.85&#x000a0;g protein/kg body weight. Therefore, we can speculate that the outpatients had adequate daily intake of protein and associated leucine. Moreover, the outpatients also had severe diseases. Therefore, their daily physical activity was low, which may have countered the leucine-induced muscle protein synthesis response even if daily intake of protein was adequate and leucine intake increased muscle protein synthesis. To increase muscle mass of older people in poor health, it might be necessary to increase physical activity and leucine intake associated with more physical activity.</p><p>Immune parameters were also evaluated in this study. Of these, NK cell activity, an index of innate immunity, increased in the outpatients and inpatients (Fig.&#x000a0;<xref ref-type="fig" rid="F1">1</xref>b). In the immune system, NK cell activity is thought to be one of the important indices for monitoring immunity because innate immunity is the first line of defense against infections. It has been shown that NK cell activity is impaired due to various stressors, such as chronic heart failure<sup>(<xref ref-type="bibr" rid="B40">40</xref>)</sup> and high-intensity physical exercise.<sup>(<xref ref-type="bibr" rid="B41">41</xref>)</sup> Moreover, it has been understood that NK cell activity is mediated, at least partially, by nitric oxide-mediated pathways.<sup>(<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>)</sup> Therefore, it is thought that arginine has a positive effect on NK cell activity because it is the only biosynthetic substrate for nitric oxide. <italic>In vitro</italic><sup>(<xref ref-type="bibr" rid="B42">42</xref>)</sup> and <italic>in vivo</italic><sup>(<xref ref-type="bibr" rid="B4">4</xref>)</sup> studies have shown that arginine administration enhances NK cell activity. The participants in this study were administered 3 kinds of amino acids. Although the relative efficacy of increased NK cell activity is difficult to estimate, arginine might have been a key factor in this result. The febrile frequency in the control inpatients showed a variation between the first and second halves of the trial, whereas that of the bedridden inpatients was stable throughout (Fig.&#x000a0;<xref ref-type="fig" rid="F2">2</xref>). This result implies that the innate immune system of the inpatients who were administered amino acids was stable due to increased NK cell activity.</p><p>Glutamine is the most abundant free amino acid in the human body. It is known to be a conditionally essential amino acid because its plasma levels decrease severely when people are critically ill.<sup>(<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>)</sup> Nosocomial infections can cause severe clinical problems in older inpatients. To prevent these infections, restoration of immune and gut-barrier functions is important.<sup>(<xref ref-type="bibr" rid="B44">44</xref>)</sup> It has been shown that glutamine supplementation increases lymphocyte count and T-lymphocyte response in surgical patients in addition to improving intestinal immune cell function.<sup>(<xref ref-type="bibr" rid="B45">45</xref>)</sup> In this study, glutamine supplementation did not increase leukocyte, lymphocyte, and monocyte counts (Table&#x000a0;<xref ref-type="table" rid="T4">4</xref>). Although the participants showed increased NK cell activity, and the febrile frequency of the inpatients was stable, our limited data did not show whether these results were directly or indirectly influenced by glutamine supplementation. Therefore, further research is required to clearly examine the effects of glutamine supplementation on health conditions in older people with poor health.</p><p>It has been observed that supplementation with more than 1&#x000a0;g/day of vitamin C improves immunity in healthy adults.<sup>(<xref ref-type="bibr" rid="B24">24</xref>)</sup> Supplementation with vitamin E in unhealthy subjects (750&#x000a0;mg/day) and in healthy elderly subjects (800&#x000a0;mg/day) enhance their immunity.<sup>(<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B46">46</xref>)</sup> The amount of administered vitamins in this study was smaller than that administered in the previous studies. Although the contribution of individual substrates to the increased NK cell activity was not identifiable, it may have partially influenced NK cell activity. This issue should be resolved in future researches.</p><p>In conclusion, this study suggested that dietary supplementation with the amino acids arginine (500&#x000a0;mg/day), glutamine (600&#x000a0;mg/day), leucine (1200&#x000a0;mg/day), and 11 kinds of vitamins for the elderly in poor health increased NK cell activity, regardless of the presence of a primary disease and the amount of the daily nutrient intake. This supplementation may be useful for supporting innate immunity and improving the health of these patients.</p></sec></body><back><ack><title>Acknowledgments</title><p>We are grateful to Junya Omotaka, Sumiko Ozaki, and Rie Miyahara (Sansei Hospital) for recruiting and administrating subjects, and to Fumishige Hinami, MD., Yuichiro Ito, MD., Kouji Sawada, MD., and Toyohiko Tsukano, MD. (Sansei Hospital) for their suggestions about all experimental procedures, and to Kosumo Kouno (Research and Development, Tokiwa Pharmaceutical Co. Ltd.) for performing all blood biomarkers evaluations.</p></ack><notes><title>Conflict of Interest</title><p>The authors have declared that no competing interests exist.</p></notes><glossary><title>Abbreviations</title><def-list><def-item><term>CRP</term><def><p>C-reactive protein</p></def></def-item><def-item><term>LBM</term><def><p>lean body mass</p></def></def-item><def-item><term>NK cell</term><def><p>natural killer cell</p></def></def-item><def-item><term>PEG</term><def><p>percutaneous endoscopic gastrostomy</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fossel</surname><given-names>M</given-names></name></person-group><article-title>Cell senescence in human aging and disease</article-title><source>Ann NY Acad Sci</source><year>2002</year><volume>959</volume><fpage>14</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">11976181</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urb&#x000e1;n</surname><given-names>L</given-names></name><name><surname>Bessenyei</surname><given-names>B</given-names></name><name><surname>M&#x000e1;rka</surname><given-names>M</given-names></name><name><surname>Semsei</surname><given-names>I</given-names></name></person-group><article-title>On the role of aging in the etiology of autoimmunity</article-title><source>Gerontology</source><year>2002</year><volume>48</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="pmid">11961373</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>KS</given-names></name><name><surname>Muscaritoli</surname><given-names>M</given-names></name><name><surname>Wischmeyer</surname><given-names>P</given-names></name><name><surname>Stehle</surname><given-names>P</given-names></name></person-group><article-title>Glutamine as indispensable nutrient in oncology: experimental and clinical evidence</article-title><source>Eur J Nutr</source><year>2010</year><volume>49</volume><fpage>197</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">19936817</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriguti</surname><given-names>JC</given-names></name><name><surname>Ferriolli</surname><given-names>E</given-names></name><name><surname>Donadi</surname><given-names>EA</given-names></name><name><surname>Marchini</surname><given-names>JS</given-names></name></person-group><article-title>Effects of arginine supplementation on the humoral and innate immune response of older people</article-title><source>Eur J Clin Nutr</source><year>2005</year><volume>59</volume><fpage>1362</fpage><lpage>1366</lpage><pub-id pub-id-type="pmid">16047027</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassit</surname><given-names>RA</given-names></name><name><surname>Sawada</surname><given-names>LA</given-names></name><name><surname>Bacurau</surname><given-names>RF</given-names></name><name><surname>Navarro</surname><given-names>F</given-names></name><name><surname>Costa Rosa</surname><given-names>LF</given-names></name></person-group><article-title>The effect of BCAA supplementation upon the immune response of triathletes</article-title><source>Med Sci Sports Exerc</source><year>2000</year><volume>32</volume><fpage>1214</fpage><lpage>1219</lpage><pub-id pub-id-type="pmid">10912884</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furukawa</surname><given-names>S</given-names></name><name><surname>Saito</surname><given-names>H</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><etal/></person-group><article-title>Supplemental glutamine augments phagocytosis and reactive oxygen intermediate production by neutrophils and monocytes from postoperative patients <italic>in vitro</italic></article-title><source>Nutrition</source><year>2000</year><volume>16</volume><fpage>323</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">10793298</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheppach</surname><given-names>W</given-names></name><name><surname>Loges</surname><given-names>C</given-names></name><name><surname>Bartram</surname><given-names>P</given-names></name><etal/></person-group><article-title>Effect of free glutamine and alanyl-glutamine dipeptide on mucosal proliferation of the human ileum and colon</article-title><source>Gastroenterology</source><year>1994</year><volume>107</volume><fpage>429</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">8039619</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCauley</surname><given-names>R</given-names></name><name><surname>Kong</surname><given-names>SE</given-names></name><name><surname>Hall</surname><given-names>J</given-names></name></person-group><article-title>Glutamine and nucleotide metabolism within enterocytes</article-title><source>JPEN J Parenter Enteral Nutr</source><year>1998</year><volume>22</volume><fpage>105</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">9527969</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wir&#x000e9;n</surname><given-names>M</given-names></name><name><surname>Magnusson</surname><given-names>KE</given-names></name><name><surname>Larsson</surname><given-names>J</given-names></name></person-group><article-title>The role of glutamine, serum and energy factors in growth of enterocyte-like cell lines</article-title><source>Int J Biochem Cell Biol</source><year>1998</year><volume>30</volume><fpage>1331</fpage><lpage>1336</lpage><pub-id pub-id-type="pmid">9924802</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>EC</given-names></name><name><surname>Patel</surname><given-names>SD</given-names></name><name><surname>Chadwick</surname><given-names>PR</given-names></name><name><surname>Warhurst</surname><given-names>G</given-names></name><name><surname>Curry</surname><given-names>A</given-names></name><name><surname>Carlson</surname><given-names>GL</given-names></name></person-group><article-title> Glutamine deprivation facilitates tumour necrosis factor induced bacterial translocation in Caco-2 cells by depletion of enterocyte fuel substrate</article-title><source>Gut</source><year>2003</year><volume>52</volume><fpage>224</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">12524404</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvalaggio</surname><given-names>PR</given-names></name><name><surname>Neto</surname><given-names>CZ</given-names></name><name><surname>Tolazzi</surname><given-names>AR</given-names></name><name><surname>Gasparetto</surname><given-names>EL</given-names></name><name><surname>Coelho</surname><given-names>JC</given-names></name><name><surname>Campos</surname><given-names>AC</given-names></name></person-group><article-title>Oral glutamine does not prevent bacterial translocation in rats subjected to intestinal obstruction and Escherichia coli challenge but reduces systemic bacteria spread</article-title><source>Nutrition</source><year>2002</year><volume>18</volume><fpage>334</fpage><lpage>337</lpage><pub-id pub-id-type="pmid">11934547</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Planas</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>S</given-names></name><name><surname>Arb&#x000f3;s</surname><given-names>MA</given-names></name><name><surname>Farriol</surname><given-names>M</given-names></name></person-group><article-title>Plasma glutamine levels in septic patients</article-title><source>JPEN J Parenter Enteral Nutr</source><year>1993</year><volume>17</volume><fpage>299</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">8505843</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houdijk</surname><given-names>AP</given-names></name><name><surname>Rijnsburger</surname><given-names>ER</given-names></name><name><surname>Jansen</surname><given-names>J</given-names></name><etal/></person-group><article-title>Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma</article-title><source>Lancet</source><year>1998</year><volume>352</volume><fpage>772</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">9737282</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>SM</given-names><suffix>Jr</suffix></name></person-group><article-title>Recent advances in arginine metabolism</article-title><source>Curr Opin Clin Nutr Metab Care</source><year>2004</year><volume>7</volume><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="pmid">15090903</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Satriano</surname><given-names>J</given-names></name></person-group><article-title>Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article</article-title><source>Amino Acids</source><year>2004</year><volume>26</volume><fpage>321</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">15290337</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbul</surname><given-names>A</given-names></name><name><surname>Rettura</surname><given-names>G</given-names></name><name><surname>Levenson</surname><given-names>SM</given-names></name><name><surname>Seifter</surname><given-names>E</given-names></name></person-group><article-title>Arginine: a thymotropic and wound-healing promoting agent</article-title><source>Surg Forum</source><year>1977</year><volume>28</volume><fpage>101</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">617386</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbul</surname><given-names>A</given-names></name><name><surname>Wasserkrug</surname><given-names>HL</given-names></name><name><surname>Yoshimura</surname><given-names>N</given-names></name><name><surname>Tao</surname><given-names>R</given-names></name><name><surname>Efron</surname><given-names>G</given-names></name></person-group><article-title>High arginine levels in intravenous hyperalimentation abrogate post-traumatic immune suppression</article-title><source>J Surg Res</source><year>1984</year><volume>36</volume><fpage>620</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">6427525</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>BC</given-names></name><name><surname>Barbul</surname><given-names>A</given-names></name></person-group><article-title>Cellular and physiological effects of arginine</article-title><source>Mini Rev Med Chem</source><year>2004</year><volume>4</volume><fpage>823</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">15544543</pub-id></element-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efron</surname><given-names>D</given-names></name><name><surname>Barbul</surname><given-names>A</given-names></name></person-group><article-title>Role of arginine in immunonutrition</article-title>. <source>J Gastroenterol</source><year>2000</year><volume>35 Suppl 12</volume><fpage>20</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">10779211</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname><given-names>JW</given-names></name></person-group><article-title>Nutritional pharmacology in surgical patients</article-title><source>Am J Surg</source><year>2002</year><volume>183</volume><fpage>349</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">11975921</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>M&#x000fc;hling</surname><given-names>J</given-names></name><name><surname>Fuchs</surname><given-names>M</given-names></name><name><surname>Fleck</surname><given-names>C</given-names></name><etal/></person-group><article-title>Effects of arginine, L-alanyl-L-glutamine or taurine on neutrophil (PMN) free amino acid profiles and immune function <italic>in vitro</italic></article-title><source>Amino Acids</source><year>2002</year><volume>22</volume><fpage>39</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">12025873</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>High</surname><given-names>KP</given-names></name></person-group><article-title>Micronutrient supplementation and immune function in the elderly</article-title><source>Clin Infect Dis</source><year>1999</year><volume>28</volume><fpage>717</fpage><lpage>722</lpage><pub-id pub-id-type="pmid">10825025</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manning</surname><given-names>RD</given-names><suffix>Jr.</suffix></name><name><surname>Tian</surname><given-names>N</given-names></name><name><surname>Meng</surname><given-names>S</given-names></name></person-group><article-title>Oxidative stress and antioxidant treatment in hypertension and the associated renal damage</article-title><source>Am J Nephrol</source><year>2005</year><volume>25</volume><fpage>311</fpage><lpage>317</lpage><pub-id pub-id-type="pmid">15956781</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wintergerst</surname><given-names>ES</given-names></name><name><surname>Maggini</surname><given-names>S</given-names></name><name><surname>Hornig</surname><given-names>DH</given-names></name></person-group><article-title>Immune-enhancing role of vitamin C and zinc and effect on clinical conditions</article-title><source>Ann Nutr Metab</source><year>2006</year><volume>50</volume><fpage>85</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">16373990</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanson</surname><given-names>MG</given-names></name><name><surname>Ozenci</surname><given-names>V</given-names></name><name><surname>Carlsten</surname><given-names>MC</given-names></name><etal/></person-group><article-title>A short-term dietary supplementation with high doses of vitamin E increases NK cell cytolytic activity in advanced colorectal cancer patients</article-title><source>Cancer Immunol Immunother</source><year>2007</year><volume>56</volume><fpage>973</fpage><lpage>984</lpage><pub-id pub-id-type="pmid">17143612</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>JC</given-names></name><name><surname>Anthony</surname><given-names>TG</given-names></name><name><surname>Kimball</surname><given-names>SR</given-names></name><name><surname>Vary</surname><given-names>TC</given-names></name><name><surname>Jefferson</surname><given-names>LS</given-names></name></person-group><article-title>Orally administered leucine stimulates protein synthesis in skeletal muscle of post absorptive rats in association with increased elF4F formation</article-title><source>J Nutr</source><year>2000</year><volume>130</volume><fpage>139</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">10720160</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>JC</given-names></name><name><surname>Yoshizawa</surname><given-names>F</given-names></name><name><surname>Anthony</surname><given-names>TG</given-names></name><name><surname>Vary</surname><given-names>TC</given-names></name><name><surname>Jefferson</surname><given-names>LS</given-names></name><name><surname>Kimball</surname><given-names>SR</given-names></name></person-group><article-title>Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway</article-title><source>J Nutr</source><year>2000</year><volume>130</volume><fpage>2413</fpage><lpage>2419</lpage><pub-id pub-id-type="pmid">11015466</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>TG</given-names></name><name><surname>Anthony</surname><given-names>JC</given-names></name><name><surname>Yoshizawa</surname><given-names>F</given-names></name><name><surname>Kimball</surname><given-names>SR</given-names></name><name><surname>Jefferson</surname><given-names>LS</given-names></name></person-group><article-title>Oral administration of leucine stimulates ribosomal protein mRNA translation but not global rates of protein synthesis in the liver of rats</article-title><source>J Nutr</source><year>2001</year><volume>131</volume><fpage>1171</fpage><lpage>1176</lpage><pub-id pub-id-type="pmid">11285321</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rieu</surname><given-names>I</given-names></name><name><surname>Balage</surname><given-names>M</given-names></name><name><surname>Sornet</surname><given-names>C</given-names></name><etal/></person-group><article-title>Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia</article-title><source>J Physiol</source><year>2006</year><volume>575</volume><fpage>305</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">16777941</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsanos</surname><given-names>CS</given-names></name><name><surname>Kobayashi</surname><given-names>H</given-names></name><name><surname>Sheffield-Moore</surname><given-names>M</given-names></name><name><surname>Aarsland</surname><given-names>A</given-names></name><name><surname>Wolfe</surname><given-names>RR</given-names></name></person-group><article-title>A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly</article-title><source>Am J Physiol Endocrinol Metab</source><year>2006</year><volume>291</volume><fpage>E381</fpage><lpage>E387</lpage><pub-id pub-id-type="pmid">16507602</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtani</surname><given-names>M</given-names></name><name><surname>Maruyama</surname><given-names>K</given-names></name><name><surname>Sugita</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name></person-group><article-title>Amino acid supplementation affects hematological and biochemical parameters in elite rugby players</article-title><source>Biosci Biotechnol Biochem</source><year>2001</year><volume>65</volume><fpage>1970</fpage><lpage>1976</lpage><pub-id pub-id-type="pmid">11676007</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtani</surname><given-names>M</given-names></name><name><surname>Maruyama</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Sugita</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name></person-group><article-title>Changes in hematological parameters of athletes after receiving daily dose of a mixture of 12 amino acids for one month during the middle- and long-distance running training</article-title><source>Biosci Biotechnol Biochem</source><year>2001</year><volume>65</volume><fpage>348</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">11302168</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>K</given-names></name><name><surname>Tsubono</surname><given-names>Y</given-names></name><name><surname>Nishino</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Validation of a food-frequency questionnaire for cohort studies in rural Japan</article-title><source>Public Health Nutr</source><year>2003</year><volume>6</volume><fpage>147</fpage><lpage>157</lpage><pub-id pub-id-type="pmid">12675957</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishiguro</surname><given-names>N</given-names></name><name><surname>Kanehisa</surname><given-names>H</given-names></name><name><surname>Miyatani</surname><given-names>M</given-names></name><name><surname>Masuo</surname><given-names>Y</given-names></name><name><surname>Fukunaga</surname><given-names>T</given-names></name></person-group><article-title>A comparison of three bioelectrical impedance analyses for predicting lean body mass in a population with a large difference in muscularity</article-title><source>Eur J Appl Physiol</source><year>2005</year><volume>94</volume><fpage>25</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">15605280</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pross</surname><given-names>HF</given-names></name><name><surname>Bainies</surname><given-names>MG</given-names></name><name><surname>Rubin</surname><given-names>P</given-names></name><name><surname>Shragge</surname><given-names>P</given-names></name><name><surname>Patterson</surname><given-names>MS</given-names></name></person-group><article-title>Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity</article-title><source>J Clin Immunol</source><year>1981</year><volume>1</volume><fpage>51</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">7334070</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>WJ</given-names></name></person-group><article-title>What is sarcopenia?</article-title><source>J Gerontol A Biol Sci Med Sci</source><year>1995</year><volume>50</volume><fpage>5</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">7493218</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frontera</surname><given-names>WR</given-names></name><name><surname>Hughes</surname><given-names>VA</given-names></name><name><surname>Fielding</surname><given-names>RA</given-names></name><name><surname>Fiatarone</surname><given-names>MA</given-names></name><name><surname>Evans</surname><given-names>WJ</given-names></name><name><surname>Roubenoff</surname><given-names>R</given-names></name></person-group><article-title>Aging of skeletal muscle: a 12-yr longitudinal study</article-title><source>J Appl Physiol</source><year>2000</year><volume>88</volume><fpage>1321</fpage><lpage>1326</lpage><pub-id pub-id-type="pmid">10749826</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhoeven</surname><given-names>S</given-names></name><name><surname>Vanschoonbeek</surname><given-names>K</given-names></name><name><surname>Verdijk</surname><given-names>LB</given-names></name><etal/></person-group><article-title>Long-term leucine supplementation does not increase muscle mass or strength in healthy elderly men</article-title><source>Am J Clin Nutr</source><year>2009</year><volume>89</volume><fpage>1468</fpage><lpage>1475</lpage><pub-id pub-id-type="pmid">19321567</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>WW</given-names></name><name><surname>Johnson</surname><given-names>CA</given-names></name><name><surname>McCabe</surname><given-names>GP</given-names></name><name><surname>Carnell</surname><given-names>NS</given-names></name></person-group><article-title>Dietary protein requirements of younger and older adults</article-title><source>Am J Clin Nutr</source><year>2008</year><volume>88</volume><fpage>1322</fpage><lpage>1329</lpage><pub-id pub-id-type="pmid">18996869</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>HC</given-names></name><name><surname>Liu</surname><given-names>SQ</given-names></name><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>LX</given-names></name></person-group><article-title>Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure</article-title><source>Heart Vessels</source><year>2009</year><volume>24</volume><fpage>283</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">19626401</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawada</surname><given-names>S</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Ohtani</surname><given-names>M</given-names></name><name><surname>Fukusaki</surname><given-names>C</given-names></name></person-group><article-title>Cystine and theanine supplementation restores high-intensity resistance exercised-induced attenuation of natural killer cell activity in well-trained men</article-title><source>J Strength Cond Res</source><year>2010</year><volume>24</volume><fpage>846</fpage><lpage>851</lpage><pub-id pub-id-type="pmid">20145562</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jyothi</surname><given-names>MD</given-names></name><name><surname>Khar</surname><given-names>A</given-names></name></person-group><article-title>Induction of nitric oxide production by natural killer cells: its role in tumor cell death</article-title><source>Nitric Oxide</source><year>1999</year><volume>3</volume><fpage>409</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">10534445</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieves</surname><given-names>C</given-names><suffix>Jr.</suffix></name><name><surname>Langkamp-Henken</surname><given-names>B</given-names></name></person-group><article-title>Arginine and immunity: a unique perspective</article-title><source>Biomed Pharmacother</source><year>2002</year><volume>56</volume><fpage>471</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">12504268</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conejero</surname><given-names>R</given-names></name><name><surname>Bonet</surname><given-names>A</given-names></name><name><surname>Grau</surname><given-names>T</given-names></name><etal/></person-group><article-title>Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study</article-title><source>Nutrition</source><year>2002</year><volume>18</volume><fpage>716</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">12297203</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Hulst</surname><given-names>RR</given-names></name><name><surname>Von Meyenfeldt</surname><given-names>MF</given-names></name><name><surname>Tiebosch</surname><given-names>A</given-names></name><name><surname>Buurman</surname><given-names>WA</given-names></name><name><surname>Soeters</surname><given-names>PB</given-names></name></person-group><article-title>Glutamine and intestinal immune cells in humans</article-title><source>JPEN J Parenter Enteral Nutr</source><year>1997</year><volume>21</volume><fpage>310</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">9406126</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meydani</surname><given-names>SN</given-names></name><name><surname>Barklund</surname><given-names>MP</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects</article-title><source>Am J Clin Nutr</source><year>1990</year><volume>52</volume><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">2203257</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Fig.&#x000a0;1</label><caption><p>Changes in body composition (a). Throughout the clinical trial, body weight (BW), lean body mass (LBM), and fat mass (FM) in the outpatients did not change with amino acid and vitamin supplementation. NK cell activity in the inpatient and outpatient groups increased with amino acid and vitamin supplementation (b).</p></caption><graphic xlink:href="jcbn11-55f01"/></fig><fig id="F2" position="float"><label>Fig.&#x000a0;2</label><caption><p>Febrile frequency (the number of days for which body temperature was more than 37&#x000b0;C/the number of days per month &#x000d7;100).</p></caption><graphic xlink:href="jcbn11-55f02"/></fig><table-wrap id="T1" position="float"><label>Table&#x000a0;1</label><caption><p>Health status and prescription drugs</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">participant</th><th align="center" rowspan="1" colspan="1">health status</th><th align="center" rowspan="1" colspan="1">prescription drugs</th><th align="center" rowspan="1" colspan="1">trial</th></tr></thead><tbody><tr><td colspan="2" align="left" rowspan="1">bedridden inpatients</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">a sequela of brain stem hemorrhage, right gastric cancer</td><td align="left" rowspan="1" colspan="1">ranitidine hydrochloride, polaprezinc, theophylline, carbocysteine, magnesium oxide, pravastatin sodium, clarithromycin</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">B</td><td align="left" rowspan="1" colspan="1">after septicemia, a sequela of cerebral infarction</td><td align="left" rowspan="1" colspan="1">polaprezinc, lactobacilli, sodium ferrous citrate, brotizolam</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="left" rowspan="1" colspan="1">a sequela of cerebral infarction</td><td align="left" rowspan="1" colspan="1">sodium picosulfate hydrate, amlodipine besylate</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1">a sequela of cerebral infarction, type 2 diabetes</td><td align="left" rowspan="1" colspan="1">sodium valproate, carbocysteine</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">E</td><td align="left" rowspan="1" colspan="1">a sequela of brain hemorrhag</td><td align="left" rowspan="1" colspan="1">digoxin, famotidine, brometon, magnesium oxide, famotidine, lactobacilli</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">F</td><td align="left" rowspan="1" colspan="1">after acute subdural hematoma</td><td align="left" rowspan="1" colspan="1">carbocysteine, ranitidine hydrochloride, lactobacilli</td><td align="center" rowspan="1" colspan="1">dropped out</td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="left" rowspan="1" colspan="1">type 2 diabetes, a sequela of cerebral infarction, obsolete myocardial infarction</td><td align="left" rowspan="1" colspan="1">nitroglyerin, tiapride hydrochloride, mosapride citrate</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">H</td><td align="left" rowspan="1" colspan="1">obsolete myocardial infarction, chronic respiratory failure, a sequela of cerebral infarction</td><td align="left" rowspan="1" colspan="1">aspirin, famotidine, furosemide, magnesium oxide, ticlopidine hydrochloride, amlodipine besylate, spironolactone, pravastatin sodium, sennoside, epinastine hydrochloride, salmeterol xinafoate</td><td align="center" rowspan="1" colspan="1">dropped out</td></tr><tr><td align="center" rowspan="1" colspan="1">I</td><td align="left" rowspan="1" colspan="1">general prostration, depression, spondylosis deformans</td><td align="left" rowspan="1" colspan="1">fluticasone propionate, carbocysteine, tiotropium bromide hydrate, clarithromycin, sulpiride</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">J</td><td align="left" rowspan="1" colspan="1">right nephrosclerosis, left ureter cancer, left brain stem hemorrhage</td><td align="left" rowspan="1" colspan="1">aspirin, lactobacilli, zopiclone, sodium picosulfate, proctosedyl</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">K</td><td align="left" rowspan="1" colspan="1">cerebellar infarction, hypertension, aspiration pneumonia, reflux esophagitis</td><td align="left" rowspan="1" colspan="1">lactobacilli, omeprazole, mosapride citrate, efonidipine hydrochloride</td><td align="center" rowspan="1" colspan="1">dropped out</td></tr><tr><td align="center" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">type 2 diabetes, pressure sore of sacral region, refractory pneumonia</td><td align="left" rowspan="1" colspan="1">enalapril maleate, aspirin, nizatidine</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">malignant lymphoma, chronic gastritis</td><td align="left" rowspan="1" colspan="1">sodium valproate, ursodeoxycholic acid, yokukansan, antibiotic-resistant lactic acid bacteria</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td colspan="2" align="left" rowspan="1">outpatients</td><td align="left" rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">N</td><td align="left" rowspan="1" colspan="1">prostate cancer, a sequela of cerebral infarction, after implant of pacemaker</td><td align="left" rowspan="1" colspan="1">amlodipine besylate, ranitidine hydrochloride, troxipide, pravastatin sodium, zopiclone, furosemide, magnesium oxide, allopurinol, digoxin, glybenclamide, aspirin</td><td align="center" rowspan="1" colspan="1">dropped out</td></tr><tr><td align="center" rowspan="1" colspan="1">O</td><td align="left" rowspan="1" colspan="1">angina pectoris, paroxysmal tachycardia, after surgery of colon cancer, atrial extrasystole</td><td align="left" rowspan="1" colspan="1">tocopherol nicotinate, dipyridamole, isosorbide dinitrate, brotizolam, nitroglyerin, sodium ferrous citrate, zolpidem tartrate</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1">left ventlicular hypertrophy, anemia after surgery of gastric cancer, refractory pneumonia</td><td align="left" rowspan="1" colspan="1">diazepam, fursultiamin, mecobalamin, omeprazole, polaprezinc, brotizolam, itoprode hydrochloride, sennoside</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">Q</td><td align="left" rowspan="1" colspan="1">chronic gastritis, impairment of liver function, hyperlipemia</td><td align="left" rowspan="1" colspan="1">azulene sulfonate sodium, vitamin B compound</td><td align="center" rowspan="1" colspan="1">dropped out</td></tr><tr><td align="center" rowspan="1" colspan="1">R</td><td align="left" rowspan="1" colspan="1">hypertension, ventricular extrasystole, overactive bladder non-neurogenic overactive bladder</td><td align="left" rowspan="1" colspan="1">tamsulosin hydrochloride, hachimijirogan, fexofenadine hydrochloride, mexiletine hydrochloride, valsartan</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">type 2 diabetes, iron deficiency anemia, diabetic peripheral neuropathy</td><td align="left" rowspan="1" colspan="1">mecobalamin, valsartan, epalrestat, cilnidipine, pioglitazone hydrochloride</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">type 2 diabetes, diabetic nephropathy, iron deficiency anemia</td><td align="left" rowspan="1" colspan="1">kalliginogenase, voglibose, fluvastatin sodium, ranitidine hydrochloride, plaunotol, difenidol hydrochloride, disopyramide</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">U</td><td align="left" rowspan="1" colspan="1">iron deficiency anemia, hypertension</td><td align="left" rowspan="1" colspan="1">losartan</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">V</td><td align="left" rowspan="1" colspan="1">cerebral infarction, hepatitis type C, liver cirrhosis, hypertension</td><td align="left" rowspan="1" colspan="1">aspirin, quinapril hydrochloride, doxazosin mesilate, enalapril maleate, trichlormethiazide, nifedipine, ranitidine hydrochloride, troxipide, sennoside, loratadine</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">W</td><td align="left" rowspan="1" colspan="1">iron deficiency anemia</td><td align="left" rowspan="1" colspan="1">Not prescripted</td><td align="center" rowspan="1" colspan="1">completed</td></tr><tr><td align="center" rowspan="1" colspan="1">X</td><td align="left" rowspan="1" colspan="1">type 2 diabetes, diabetic peripheral neuropathy</td><td align="left" rowspan="1" colspan="1">glybenclamide, alfacalcidol, ranitidine hydrochloride, flurbiprofen, azulene sulfonate sodium</td><td align="center" rowspan="1" colspan="1">completed</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float"><label>Table&#x000a0;2</label><caption><p>Liquid diet composition/pack (2000&#x000a0;kcal/1000&#x000a0;ml)</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">carbohydrate (g)</td><td align="center" rowspan="1" colspan="1">246</td><td align="left" rowspan="1" colspan="1">minerals (mg)</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">vitamins</td><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">amino acids (g)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">fat (g)</td><td align="center" rowspan="1" colspan="1">86</td><td align="left" rowspan="1" colspan="1">potassium</td><td align="center" rowspan="1" colspan="1">1496</td><td align="left" rowspan="1" colspan="1">vitamin A (&#x000b5;g)</td><td align="center" rowspan="1" colspan="1">1496.3</td><td align="left" rowspan="1" colspan="1">isoleucine</td><td align="center" rowspan="1" colspan="1">3.2</td><td align="left" rowspan="1" colspan="1">arginine</td><td align="center" rowspan="1" colspan="1">2.1</td></tr><tr><td align="left" rowspan="1" colspan="1">sodium (g)</td><td align="center" rowspan="1" colspan="1">0.5</td><td align="left" rowspan="1" colspan="1">calcium</td><td align="center" rowspan="1" colspan="1">1103</td><td align="left" rowspan="1" colspan="1">vitamin B1 (mg)</td><td align="center" rowspan="1" colspan="1">4.0</td><td align="left" rowspan="1" colspan="1">leucine</td><td align="center" rowspan="1" colspan="1">6.0</td><td align="left" rowspan="1" colspan="1">glycine</td><td align="center" rowspan="1" colspan="1">1.2</td></tr><tr><td align="left" rowspan="1" colspan="1">dietary fiber (g)</td><td align="center" rowspan="1" colspan="1">1.7</td><td align="left" rowspan="1" colspan="1">magnesium</td><td align="center" rowspan="1" colspan="1">359</td><td align="left" rowspan="1" colspan="1">vitamin B2 (mg)</td><td align="center" rowspan="1" colspan="1">4.62</td><td align="left" rowspan="1" colspan="1">lysine</td><td align="center" rowspan="1" colspan="1">5.0</td><td align="left" rowspan="1" colspan="1">alanine</td><td align="center" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" rowspan="1" colspan="1">water</td><td align="center" rowspan="1" colspan="1">700 mL</td><td align="left" rowspan="1" colspan="1">phosphorus</td><td align="center" rowspan="1" colspan="1">1148</td><td align="left" rowspan="1" colspan="1">vitamin B6 (mg)</td><td align="center" rowspan="1" colspan="1">5.04</td><td align="left" rowspan="1" colspan="1">methionine</td><td align="center" rowspan="1" colspan="1">1.8</td><td align="left" rowspan="1" colspan="1">serine</td><td align="center" rowspan="1" colspan="1">3.7</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">iron</td><td align="center" rowspan="1" colspan="1">25.0</td><td align="left" rowspan="1" colspan="1">vitamin B12 (&#x000b5;g)</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">cystine</td><td align="center" rowspan="1" colspan="1">0.2</td><td align="left" rowspan="1" colspan="1">aspartic acid</td><td align="center" rowspan="1" colspan="1">4.6</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">zinc</td><td align="center" rowspan="1" colspan="1">18.90</td><td align="left" rowspan="1" colspan="1">vitamin C (mg)</td><td align="center" rowspan="1" colspan="1">349.7</td><td align="left" rowspan="1" colspan="1">phenylalanine</td><td align="center" rowspan="1" colspan="1">3.4</td><td align="left" rowspan="1" colspan="1">glutamate</td><td align="center" rowspan="1" colspan="1">14.7</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">copper</td><td align="center" rowspan="1" colspan="1">3.0</td><td align="left" rowspan="1" colspan="1">vitamin D (&#x000b5;g)</td><td align="center" rowspan="1" colspan="1">9.98</td><td align="left" rowspan="1" colspan="1">tyrosine</td><td align="center" rowspan="1" colspan="1">2.7</td><td align="left" rowspan="1" colspan="1">proline</td><td align="center" rowspan="1" colspan="1">7.2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">manganese</td><td align="center" rowspan="1" colspan="1">0.16</td><td align="left" rowspan="1" colspan="1">vitamin E (mg)</td><td align="center" rowspan="1" colspan="1">18.0</td><td align="left" rowspan="1" colspan="1">threonine</td><td align="center" rowspan="1" colspan="1">2.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">chlorine</td><td align="center" rowspan="1" colspan="1">998</td><td align="left" rowspan="1" colspan="1">niacin (mg)</td><td align="center" rowspan="1" colspan="1">53.9</td><td align="left" rowspan="1" colspan="1">tryptophan</td><td align="center" rowspan="1" colspan="1">0.8</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">selenium (&#x000b5;g)</td><td align="center" rowspan="1" colspan="1">89.8</td><td align="left" rowspan="1" colspan="1">folic acid (&#x000b5;g)</td><td align="center" rowspan="1" colspan="1">399.0</td><td align="left" rowspan="1" colspan="1">valine</td><td align="center" rowspan="1" colspan="1">4.1</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">pantothenic acid (mg)</td><td align="center" rowspan="1" colspan="1">25.0</td><td align="left" rowspan="1" colspan="1">histidine</td><td align="center" rowspan="1" colspan="1">2.0</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><table-wrap id="T3" position="float"><label>Table&#x000a0;3</label><caption><p>Amino acid and vitamin composition/pack</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">amino acid</th><th align="center" rowspan="1" colspan="1">(mg)</th><th align="left" rowspan="1" colspan="1">vitamin</th><th align="center" rowspan="1" colspan="1">(mg)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">arginine</td><td align="center" rowspan="1" colspan="1">250</td><td align="left" rowspan="1" colspan="1">vitamin A</td><td align="center" rowspan="1" colspan="1">0.45</td></tr><tr><td align="left" rowspan="1" colspan="1">glutamine</td><td align="center" rowspan="1" colspan="1">300</td><td align="left" rowspan="1" colspan="1">vitamin B1</td><td align="center" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" rowspan="1" colspan="1">leucine</td><td align="center" rowspan="1" colspan="1">600</td><td align="left" rowspan="1" colspan="1">vitamin B2</td><td align="center" rowspan="1" colspan="1">1.6</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">vitamin B6</td><td align="center" rowspan="1" colspan="1">2.0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">vitamin B12</td><td align="center" rowspan="1" colspan="1">0.004</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">vitamin C</td><td align="center" rowspan="1" colspan="1">170</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">vitamin D</td><td align="center" rowspan="1" colspan="1">0.005</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">vitamin E</td><td align="center" rowspan="1" colspan="1">8.0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">niacinamide</td><td align="center" rowspan="1" colspan="1">11.0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">folic acid</td><td align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">pantothenic acid</td><td align="center" rowspan="1" colspan="1">5.5</td></tr></tbody></table></table-wrap><table-wrap id="T4" position="float"><label>Table&#x000a0;4</label><caption><p>Hematological and biochemical parameters</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">baseline</th><th align="center" rowspan="1" colspan="1">mid-point</th><th align="center" rowspan="1" colspan="1">post-point</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">erythrocyte (million/&#x000b5;l)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">3.97&#x000a0;&#x000b1;&#x000a0;0.74</td><td align="center" rowspan="1" colspan="1">4.02&#x000a0;&#x000b1;&#x000a0;0.63</td><td align="center" rowspan="1" colspan="1">4.04&#x000a0;&#x000b1;&#x000a0;0.59</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">3.97&#x000a0;&#x000b1;&#x000a0;0.25</td><td align="center" rowspan="1" colspan="1">3.89&#x000a0;&#x000b1;&#x000a0;0.28</td><td align="center" rowspan="1" colspan="1">3.87&#x000a0;&#x000b1;&#x000a0;0.21</td></tr><tr><td align="left" rowspan="1" colspan="1">hemoglobin (g/dl)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">12.22&#x000a0;&#x000b1;&#x000a0;2.04</td><td align="center" rowspan="1" colspan="1">12.37&#x000a0;&#x000b1;&#x000a0;1.77</td><td align="center" rowspan="1" colspan="1">12.52&#x000a0;&#x000b1;&#x000a0;1.53</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">11.92&#x000a0;&#x000b1;&#x000a0;1.32</td><td align="center" rowspan="1" colspan="1">11.73&#x000a0;&#x000b1;&#x000a0;1.48</td><td align="center" rowspan="1" colspan="1">11.61&#x000a0;&#x000b1;&#x000a0;1.24</td></tr><tr><td align="left" rowspan="1" colspan="1">Ht (%)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">38.0&#x000a0;&#x000b1;&#x000a0;6.2</td><td align="center" rowspan="1" colspan="1">38.5&#x000a0;&#x000b1;&#x000a0;5.4</td><td align="center" rowspan="1" colspan="1">38.8&#x000a0;&#x000b1;&#x000a0;4.9</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">36.8&#x000a0;&#x000b1;&#x000a0;3.2</td><td align="center" rowspan="1" colspan="1">36.8&#x000a0;&#x000b1;&#x000a0;3.5</td><td align="center" rowspan="1" colspan="1">36.4&#x000a0;&#x000b1;&#x000a0;3.0</td></tr><tr><td align="left" rowspan="1" colspan="1">platelet (thousand/&#x000b5;l)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">243.4&#x000a0;&#x000b1;&#x000a0;42.8</td><td align="center" rowspan="1" colspan="1">240.6&#x000a0;&#x000b1;&#x000a0;44.1</td><td align="center" rowspan="1" colspan="1">248.8&#x000a0;&#x000b1;&#x000a0;38.0</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">218.1&#x000a0;&#x000b1;&#x000a0;63.9</td><td align="center" rowspan="1" colspan="1">209.2&#x000a0;&#x000b1;&#x000a0;5.87</td><td align="center" rowspan="1" colspan="1">216.7&#x000a0;&#x000b1;&#x000a0;70.5</td></tr><tr><td align="left" rowspan="1" colspan="1">leukocyte (/&#x000b5;l)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">7320&#x000a0;&#x000b1;&#x000a0;1530</td><td align="center" rowspan="1" colspan="1">7860&#x000a0;&#x000b1;&#x000a0;1680</td><td align="center" rowspan="1" colspan="1">7310&#x000a0;&#x000b1;&#x000a0;1290</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">5230&#x000a0;&#x000b1;&#x000a0;1260</td><td align="center" rowspan="1" colspan="1">5120&#x000a0;&#x000b1;&#x000a0;1070</td><td align="center" rowspan="1" colspan="1">4820&#x000a0;&#x000b1;&#x000a0;870</td></tr><tr><td align="left" rowspan="1" colspan="1">basophilic leukocyte (%)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">0.50&#x000a0;&#x000b1;&#x000a0;0.37</td><td align="center" rowspan="1" colspan="1">0.63&#x000a0;&#x000b1;&#x000a0;0.60</td><td align="center" rowspan="1" colspan="1">0.67&#x000a0;&#x000b1;&#x000a0;0.56</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">0.64&#x000a0;&#x000b1;&#x000a0;0.30</td><td align="center" rowspan="1" colspan="1">0.50&#x000a0;&#x000b1;&#x000a0;0.32</td><td align="center" rowspan="1" colspan="1">0.49&#x000a0;&#x000b1;&#x000a0;0.36</td></tr><tr><td align="left" rowspan="1" colspan="1">neutrophilic leukocyte (%)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">52.54&#x000a0;&#x000b1;&#x000a0;8.87</td><td align="center" rowspan="1" colspan="1">57.72&#x000a0;&#x000b1;&#x000a0;10.04</td><td align="center" rowspan="1" colspan="1">54.26&#x000a0;&#x000b1;&#x000a0;7.63</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">56.76&#x000a0;&#x000b1;&#x000a0;13.47</td><td align="center" rowspan="1" colspan="1">56.66&#x000a0;&#x000b1;&#x000a0;12.52</td><td align="center" rowspan="1" colspan="1">53.37&#x000a0;&#x000b1;&#x000a0;12.86</td></tr><tr><td align="left" rowspan="1" colspan="1">acidophilic leukocyte (%)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">6.11&#x000a0;&#x000b1;&#x000a0;7.32</td><td align="center" rowspan="1" colspan="1">5.88&#x000a0;&#x000b1;&#x000a0;7.04</td><td align="center" rowspan="1" colspan="1">5.97&#x000a0;&#x000b1;&#x000a0;6.62</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">2.36&#x000a0;&#x000b1;&#x000a0;1.71</td><td align="center" rowspan="1" colspan="1">2.07&#x000a0;&#x000b1;&#x000a0;1.35</td><td align="center" rowspan="1" colspan="1">2.08&#x000a0;&#x000b1;&#x000a0;1.44</td></tr><tr><td align="left" rowspan="1" colspan="1">lymphocyte (%)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">34.30&#x000a0;&#x000b1;&#x000a0;4.72</td><td align="center" rowspan="1" colspan="1">28.36&#x000a0;&#x000b1;&#x000a0;5.66</td><td align="center" rowspan="1" colspan="1">32.51&#x000a0;&#x000b1;&#x000a0;5.07</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">33.80&#x000a0;&#x000b1;&#x000a0;12.88</td><td align="center" rowspan="1" colspan="1">34.46&#x000a0;&#x000b1;&#x000a0;10.80</td><td align="center" rowspan="1" colspan="1">36.62&#x000a0;&#x000b1;&#x000a0;12.51</td></tr><tr><td align="left" rowspan="1" colspan="1">monocyte (%)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">6.55&#x000a0;&#x000b1;&#x000a0;1.95</td><td align="center" rowspan="1" colspan="1">7.21&#x000a0;&#x000b1;&#x000a0;2.28</td><td align="center" rowspan="1" colspan="1">6.59&#x000a0;&#x000b1;&#x000a0;1.40</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">6.44&#x000a0;&#x000b1;&#x000a0;1.07</td><td align="center" rowspan="1" colspan="1">6.32&#x000a0;&#x000b1;&#x000a0;1.78</td><td align="center" rowspan="1" colspan="1">7.44&#x000a0;&#x000b1;&#x000a0;2.64</td></tr><tr><td align="left" rowspan="1" colspan="1">total plasma protein (g/dl)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">6.98&#x000a0;&#x000b1;&#x000a0;0.58</td><td align="center" rowspan="1" colspan="1">7.01&#x000a0;&#x000b1;&#x000a0;0.62</td><td align="center" rowspan="1" colspan="1">7.07&#x000a0;&#x000b1;&#x000a0;0.54</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">7.12&#x000a0;&#x000b1;&#x000a0;0.56</td><td align="center" rowspan="1" colspan="1">7.13&#x000a0;&#x000b1;&#x000a0;0.54</td><td align="center" rowspan="1" colspan="1">7.10&#x000a0;&#x000b1;&#x000a0;0.44</td></tr><tr><td align="left" rowspan="1" colspan="1">albumin (g/dl)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">3.58&#x000a0;&#x000b1;&#x000a0;0.29</td><td align="center" rowspan="1" colspan="1">3.62&#x000a0;&#x000b1;&#x000a0;0.31</td><td align="center" rowspan="1" colspan="1">3.64&#x000a0;&#x000b1;&#x000a0;0.24</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">4.12&#x000a0;&#x000b1;&#x000a0;0.23</td><td align="center" rowspan="1" colspan="1">4.11&#x000a0;&#x000b1;&#x000a0;0.34</td><td align="center" rowspan="1" colspan="1">4.14&#x000a0;&#x000b1;&#x000a0;0.29</td></tr><tr><td align="left" rowspan="1" colspan="1">total bilirubin (mg/dl)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">0.29&#x000a0;&#x000b1;&#x000a0;0.09</td><td align="center" rowspan="1" colspan="1">0.35&#x000a0;&#x000b1;&#x000a0;0.14</td><td align="center" rowspan="1" colspan="1">0.35&#x000a0;&#x000b1;&#x000a0;0.15</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">0.61&#x000a0;&#x000b1;&#x000a0;0.23</td><td align="center" rowspan="1" colspan="1">0.56&#x000a0;&#x000b1;&#x000a0;0.13</td><td align="center" rowspan="1" colspan="1">0.56&#x000a0;&#x000b1;&#x000a0;0.11</td></tr><tr><td align="left" rowspan="1" colspan="1">aspartate aminotransferase (IU/L)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">28.70&#x000a0;&#x000b1;&#x000a0;15.05</td><td align="center" rowspan="1" colspan="1">36.00&#x000a0;&#x000b1;&#x000a0;23.71</td><td align="center" rowspan="1" colspan="1">23.20&#x000a0;&#x000b1;&#x000a0;5.49</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">29.22&#x000a0;&#x000b1;&#x000a0;18.98</td><td align="center" rowspan="1" colspan="1">25.44&#x000a0;&#x000b1;&#x000a0;5.29</td><td align="center" rowspan="1" colspan="1">27.33&#x000a0;&#x000b1;&#x000a0;6.56</td></tr><tr><td align="left" rowspan="1" colspan="1">alanine aminotransferase (IU/L)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">20.20&#x000a0;&#x000b1;&#x000a0;13.81</td><td align="center" rowspan="1" colspan="1">32.70&#x000a0;&#x000b1;&#x000a0;28.28</td><td align="center" rowspan="1" colspan="1">20.70&#x000a0;&#x000b1;&#x000a0;10.09</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">22.78&#x000a0;&#x000b1;&#x000a0;21.24</td><td align="center" rowspan="1" colspan="1">19.11&#x000a0;&#x000b1;&#x000a0;6.19</td><td align="center" rowspan="1" colspan="1">20.33&#x000a0;&#x000b1;&#x000a0;8.03</td></tr><tr><td align="left" rowspan="1" colspan="1">leucine aminopeptidase (IU/L)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">45.00&#x000a0;&#x000b1;&#x000a0;11.05</td><td align="center" rowspan="1" colspan="1">47.89&#x000a0;&#x000b1;&#x000a0;14.15</td><td align="center" rowspan="1" colspan="1">47.00&#x000a0;&#x000b1;&#x000a0;12.76</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">38.89&#x000a0;&#x000b1;&#x000a0;5.23</td><td align="center" rowspan="1" colspan="1">38.67&#x000a0;&#x000b1;&#x000a0;4.61</td><td align="center" rowspan="1" colspan="1">38.89&#x000a0;&#x000b1;&#x000a0;2.89</td></tr><tr><td align="left" rowspan="1" colspan="1">cholinesterase (IU/L)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">3772&#x000a0;&#x000b1;&#x000a0;940</td><td align="center" rowspan="1" colspan="1">3770&#x000a0;&#x000b1;&#x000a0;821</td><td align="center" rowspan="1" colspan="1">3940&#x000a0;&#x000b1;&#x000a0;836</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">3754&#x000a0;&#x000b1;&#x000a0;637</td><td align="center" rowspan="1" colspan="1">3722&#x000a0;&#x000b1;&#x000a0;816</td><td align="center" rowspan="1" colspan="1">3798&#x000a0;&#x000b1;&#x000a0;775</td></tr><tr><td align="left" rowspan="1" colspan="1">gamma-glutamyltranspeptidase (IU/L)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">30.40&#x000a0;&#x000b1;&#x000a0;23.19</td><td align="center" rowspan="1" colspan="1">38.30&#x000a0;&#x000b1;&#x000a0;28.74</td><td align="center" rowspan="1" colspan="1">35.50&#x000a0;&#x000b1;&#x000a0;31.87</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">16.89&#x000a0;&#x000b1;&#x000a0;6.47</td><td align="center" rowspan="1" colspan="1">16.78&#x000a0;&#x000b1;&#x000a0;6.94</td><td align="center" rowspan="1" colspan="1">16.67&#x000a0;&#x000b1;&#x000a0;4.61</td></tr><tr><td align="left" rowspan="1" colspan="1">blood urea nitrogen (mg/dl)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">21.80&#x000a0;&#x000b1;&#x000a0;7.97</td><td align="center" rowspan="1" colspan="1">22.80&#x000a0;&#x000b1;&#x000a0;9.60</td><td align="center" rowspan="1" colspan="1">23.10&#x000a0;&#x000b1;&#x000a0;8.20</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">15.44&#x000a0;&#x000b1;&#x000a0;3.97</td><td align="center" rowspan="1" colspan="1">16.22&#x000a0;&#x000b1;&#x000a0;4.89</td><td align="center" rowspan="1" colspan="1">16.11&#x000a0;&#x000b1;&#x000a0;3.37</td></tr><tr><td align="left" rowspan="1" colspan="1">serum creatinine (mg/dl)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">0.63&#x000a0;&#x000b1;&#x000a0;0.18</td><td align="center" rowspan="1" colspan="1">0.61&#x000a0;&#x000b1;&#x000a0;0.15</td><td align="center" rowspan="1" colspan="1">0.67&#x000a0;&#x000b1;&#x000a0;0.20</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">0.73&#x000a0;&#x000b1;&#x000a0;0.18</td><td align="center" rowspan="1" colspan="1">0.75&#x000a0;&#x000b1;&#x000a0;0.21</td><td align="center" rowspan="1" colspan="1">0.76&#x000a0;&#x000b1;&#x000a0;0.21</td></tr><tr><td align="left" rowspan="1" colspan="1">serum amylase (IU/L)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">90.90&#x000a0;&#x000b1;&#x000a0;33.00</td><td align="center" rowspan="1" colspan="1">85.80&#x000a0;&#x000b1;&#x000a0;32.58</td><td align="center" rowspan="1" colspan="1">84.40&#x000a0;&#x000b1;&#x000a0;31.44</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">97.11&#x000a0;&#x000b1;&#x000a0;51.61</td><td align="center" rowspan="1" colspan="1">97.44&#x000a0;&#x000b1;&#x000a0;45.45</td><td align="center" rowspan="1" colspan="1">100.33&#x000a0;&#x000b1;&#x000a0;16.92</td></tr><tr><td align="left" rowspan="1" colspan="1">CRP (mg/dl)</td><td align="center" rowspan="1" colspan="1">inpatients</td><td align="center" rowspan="1" colspan="1">1.02&#x000a0;&#x000b1;&#x000a0;1.79</td><td align="center" rowspan="1" colspan="1">1.18&#x000a0;&#x000b1;&#x000a0;1.21</td><td align="center" rowspan="1" colspan="1">1.38&#x000a0;&#x000b1;&#x000a0;2.81</td></tr><tr><td rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">outpatients</td><td align="center" rowspan="1" colspan="1">0.29&#x000a0;&#x000b1;&#x000a0;0.52</td><td align="center" rowspan="1" colspan="1">0.06&#x000a0;&#x000b1;&#x000a0;0.06</td><td align="center" rowspan="1" colspan="1">0.04&#x000a0;&#x000b1;&#x000a0;0.04</td></tr></tbody></table></table-wrap></floats-group></article>